Expression of Concern to: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases.


Journal

Clinical and translational medicine
ISSN: 2001-1326
Titre abrégé: Clin Transl Med
Pays: United States
ID NLM: 101597971

Informations de publication

Date de publication:
06 02 2019
Historique:
received: 11 01 2019
accepted: 14 01 2019
entrez: 7 2 2019
pubmed: 7 2 2019
medline: 7 2 2019
Statut: epublish

Résumé

The Editor of this journal has published this Expression of Concern to alert readers that, following publication of the article [1], it came to light that there were undeclared competing interests that have a direct impact on the article and the strength of its findings. In addition, post publication peer review has indicated that the conclusions may not be supported by the results due to methodological flaws in the study. Pending further investigation of these concerns, further editorial action may be taken. The authors have not responded to any correspondence about this Expression of Concern.

Identifiants

pubmed: 30725243
doi: 10.1186/s40169-019-0222-0
pii: 10.1186/s40169-019-0222-0
pmc: PMC6365573
doi:

Types de publication

Journal Article Expression of Concern

Langues

eng

Pagination

5

Commentaires et corrections

Type : ExpressionOfConcernFor

Références

Clin Transl Med. 2016 Dec;5(1):40
pubmed: 27766602

Auteurs

Hanan Polansky (H)

The Center for the Biology of Chronic Disease (CBCD), 616 Corporate Way, Suite 2-3665, Valley Cottage, NY, 10989, USA. hpolansky@cbcd.net.

Edan Itzkovitz (E)

The Center for the Biology of Chronic Disease (CBCD), 616 Corporate Way, Suite 2-3665, Valley Cottage, NY, 10989, USA.

Adrian Javaherian (A)

The Center for the Biology of Chronic Disease (CBCD), 616 Corporate Way, Suite 2-3665, Valley Cottage, NY, 10989, USA.

Classifications MeSH